BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37329936)

  • 1. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results.
    Pachon JC; Pachon EI; Cunha Pachon MZ; Lobo TJ; Pachon JC; Santillana TG
    Europace; 2011 Sep; 13(9):1231-42. PubMed ID: 21712276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.
    Piotrowski R; Baran J; Sikorska A; Krynski T; Kulakowski P
    JACC Clin Electrophysiol; 2023 Jan; 9(1):85-95. PubMed ID: 36114133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation.
    Aksu T; Guler TE; Bozyel S; Yalin K; Gopinathannair R
    Europace; 2020 Sep; 22(9):1320-1327. PubMed ID: 32898255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B; Morillo CA; Sheldon RS; Chew DS; Aksu T; Raj SR
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.
    Tu B; Wu L; Hu F; Fan S; Liu S; Liu L; Ding L; Zheng L; Yao Y
    Heart Rhythm; 2022 Apr; 19(4):562-569. PubMed ID: 34896621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioneuroablation changes the type of vasovagal response in patients with asystolic reflex syncope.
    Piotrowski R; Żuk A; Baran J; Sikorska A; Kryński T; Kułakowski P
    Auton Neurosci; 2021 Nov; 235():102838. PubMed ID: 34186273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study.
    Aksu T; Padmanabhan D; Shenthar J; Yalin K; Gautam S; Valappil SP; Banavalikar B; Guler TE; Bozyel S; Tanboga IH; Lakkireddy D; Olshansky RB; Gopinathannair R
    J Interv Card Electrophysiol; 2022 Jan; 63(1):77-86. PubMed ID: 33527216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioneuroablation for the Treatment of Vasovagal Syncope: Current Status and Impact on Quality of Life.
    Traykov V; Shalganov T
    Curr Cardiol Rep; 2023 Dec; 25(12):1839-1849. PubMed ID: 37982935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T; Chung MK
    Curr Cardiovasc Risk Rep; 2024 Apr; 18(4):55-64. PubMed ID: 38707611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials.
    Chakraborty P; Chen PS; Gollob MH; Olshansky B; Po SS
    Heart Rhythm; 2024 Apr; 21(4):464-470. PubMed ID: 38104955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study.
    Aksu T; Guler TE; Mutluer FO; Bozyel S; Golcuk SE; Yalin K
    J Interv Card Electrophysiol; 2019 Mar; 54(2):177-188. PubMed ID: 30054828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioneuroablation for reflex asystolic syncope: Mid-term safety, efficacy, and patient's acceptance.
    Kulakowski P; Baran J; Sikorska A; Krynski T; Niedzwiedz M; Soszynska M; Piotrowski R
    Heart Rhythm; 2024 Mar; 21(3):282-291. PubMed ID: 38036236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term results of cardioneuroablation for clinical bradyarrhythmias and vasovagal syncope: effects on QT interval and heart rate.
    Aksu T; Guler TE; Bozyel S; Golcuk SE; Yalin K; Lakkireddy D; Gopinathannair R
    J Interv Card Electrophysiol; 2021 Jan; 60(1):57-68. PubMed ID: 32034611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right anterior ganglionated plexus: The primary target of cardioneuroablation?
    Hu F; Zheng L; Liang E; Ding L; Wu L; Chen G; Fan X; Yao Y
    Heart Rhythm; 2019 Oct; 16(10):1545-1551. PubMed ID: 31330187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely vasovagal syncope.
    Petix NR; Del Rosso A; Furlan R; Guarnaccia V; Zipoli A
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):164-72. PubMed ID: 23992559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.
    Aksu T; Tung R; De Potter T; Markman TM; Santangeli P; du Fay de Lavallaz J; Winterfield JR; Baykaner T; Alyesh D; Joza JE; Gopinathannair R; Badertscher P; Do DH; Hussein A; Osorio J; Dewland T; Perino A; Rodgers AJ; DeSimone C; Alfie A; Atwater BD; Singh D; Kumar K; Salcedo J; Bradfield JS; Upadhyay G; Sood N; Sharma PS; Gautam S; Kumar V; Forno ARJD; Woods CE; Rav-Acha M; Valeriano C; Kapur S; Enriquez A; Sundaram S; Glikson M; Gerstenfeld E; Piccini J; Tzou WS; Sauer W; d'Avila A; Shivkumar K; Huang HD
    J Interv Card Electrophysiol; 2024 Mar; ():. PubMed ID: 38499825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved health-related quality of life after cardioneuroablation in patients with vasovagal syncope.
    Baysal E; Mutluer FO; Dagsali AE; Kumrulu UC; Huang HD; Aksu T
    J Interv Card Electrophysiol; 2022 Nov; ():. PubMed ID: 36357697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioneuroablation for cardioinhibitory vasovagal syncope.
    John LA; Mullis A; Payne J; Tung R; Aksu T; Winterfield JR
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1748-1753. PubMed ID: 33855779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of cerebral oximetry during head-up tilt test in adults with history of syncope and orthostatic intolerance.
    Bachus E; Holm H; Hamrefors V; Melander O; Sutton R; Magnusson M; Fedorowski A
    Europace; 2018 Sep; 20(9):1535-1542. PubMed ID: 29036615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.